NVS

Novartis AG

137.70

USD

NVS Earnings Reports

Positive Surprise Ratio

NVS beat 24 of 39 last estimates.

62%

Next Report

Date of Next Report

Feb 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

$14.11B

$1.98

Implied change from Q3 25 (Revenue/ EPS)

+1.41%

-12.00%

Implied change from Q4 24 (Revenue/ EPS)

+7.24%

Novartis AG earnings per share and revenue

On Oct 28, 2025, NVS reported earnings of 2.25 USD per share (EPS) for Q3 25, missing the estimate of 2.29 USD, resulting in a -2.11% surprise. Revenue reached 13.91 billion, compared to an expected 14.31 billion, with a -2.81% difference. The market reacted with a -4.42% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 8 analysts forecast an EPS of 1.98 USD, with revenue projected to reach 14.11 billion USD, implying an decrease of -12.00% EPS, and increase of 1.41% in Revenue from the last quarter.

FAQ

What were Novartis AG's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Novartis AG reported EPS of $2.25, missing estimates by -2.11%, and revenue of $13.91B, -2.81% below expectations.

How did the market react to Novartis AG's Q3 2025 earnings?

The stock price moved down -4.42%, changed from $129.14 before the earnings release to $123.43 the day after.

When is Novartis AG expected to report next?

The next earning report is scheduled for Feb 04, 2026.

What are the forecasts for Novartis AG's next earnings report?

Based on 8 analysts, Novartis AG is expected to report EPS of $1.98 and revenue of $14.11B for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.